Gentamicin pharmacokinetics in neonates undergoing therapeutic hypothermia

Liana F. Mark, Addishiwot Solomon, Frances Northington, Carlton K Lee

Research output: Contribution to journalArticle

Abstract

OBJECTIVE:: To identify whether therapeutic hypothermia in newborns with hypoxic ischemic encephalopathy affects gentamicin pharmacokinetics. STUDY DESIGN:: Retrospective case-control study consisting of 16 neonates who underwent therapeutic hypothermia and received gentamicin with interpretable peak and trough serum levels obtained during the period of cooling and at steady state; comparator group consisting of 7 neonates met the criteria but did not undergo therapeutic hypothermia. RESULTS:: Significant differences in gentamicin pharmacokinetics were noted between the therapeutic hypothermia group and the comparator group in elimination rate constant (0.08/h versus 0.11/h; P <0.01), elimination half-life (9.16 hours versus 6.56 hours; P <0.01), and clearance (0.04 L/kg.h versus 0.05 L/kg.h; P <0.01), respectively. Higher gentamicin trough serum concentrations were seen with the therapeutic hypothermia group (1.68 mcg/mL versus 0.77 mcg/mL; P <0.01). CONCLUSIONS:: Therapeutic hypothermia is associated with alterations in gentamicin pharmacokinetics, reducing gentamicin clearance by 25.5% in neonates with hypoxic ischemic encephalopathy, which may result in increased trough serum concentrations.

Original languageEnglish (US)
Pages (from-to)217-222
Number of pages6
JournalTherapeutic Drug Monitoring
Volume35
Issue number2
DOIs
StatePublished - Apr 2013

Fingerprint

Induced Hypothermia
Gentamicins
Pharmacokinetics
Brain Hypoxia-Ischemia
Serum
Half-Life
Case-Control Studies

Keywords

  • aminoglycoside
  • cooling
  • hypoxic ischemic encephalopathy

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology

Cite this

Gentamicin pharmacokinetics in neonates undergoing therapeutic hypothermia. / Mark, Liana F.; Solomon, Addishiwot; Northington, Frances; Lee, Carlton K.

In: Therapeutic Drug Monitoring, Vol. 35, No. 2, 04.2013, p. 217-222.

Research output: Contribution to journalArticle

@article{3cfd950977db4581bd58ef6208f93bc0,
title = "Gentamicin pharmacokinetics in neonates undergoing therapeutic hypothermia",
abstract = "OBJECTIVE:: To identify whether therapeutic hypothermia in newborns with hypoxic ischemic encephalopathy affects gentamicin pharmacokinetics. STUDY DESIGN:: Retrospective case-control study consisting of 16 neonates who underwent therapeutic hypothermia and received gentamicin with interpretable peak and trough serum levels obtained during the period of cooling and at steady state; comparator group consisting of 7 neonates met the criteria but did not undergo therapeutic hypothermia. RESULTS:: Significant differences in gentamicin pharmacokinetics were noted between the therapeutic hypothermia group and the comparator group in elimination rate constant (0.08/h versus 0.11/h; P <0.01), elimination half-life (9.16 hours versus 6.56 hours; P <0.01), and clearance (0.04 L/kg.h versus 0.05 L/kg.h; P <0.01), respectively. Higher gentamicin trough serum concentrations were seen with the therapeutic hypothermia group (1.68 mcg/mL versus 0.77 mcg/mL; P <0.01). CONCLUSIONS:: Therapeutic hypothermia is associated with alterations in gentamicin pharmacokinetics, reducing gentamicin clearance by 25.5{\%} in neonates with hypoxic ischemic encephalopathy, which may result in increased trough serum concentrations.",
keywords = "aminoglycoside, cooling, hypoxic ischemic encephalopathy",
author = "Mark, {Liana F.} and Addishiwot Solomon and Frances Northington and Lee, {Carlton K}",
year = "2013",
month = "4",
doi = "10.1097/FTD.0b013e3182834335",
language = "English (US)",
volume = "35",
pages = "217--222",
journal = "Therapeutic Drug Monitoring",
issn = "0163-4356",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Gentamicin pharmacokinetics in neonates undergoing therapeutic hypothermia

AU - Mark, Liana F.

AU - Solomon, Addishiwot

AU - Northington, Frances

AU - Lee, Carlton K

PY - 2013/4

Y1 - 2013/4

N2 - OBJECTIVE:: To identify whether therapeutic hypothermia in newborns with hypoxic ischemic encephalopathy affects gentamicin pharmacokinetics. STUDY DESIGN:: Retrospective case-control study consisting of 16 neonates who underwent therapeutic hypothermia and received gentamicin with interpretable peak and trough serum levels obtained during the period of cooling and at steady state; comparator group consisting of 7 neonates met the criteria but did not undergo therapeutic hypothermia. RESULTS:: Significant differences in gentamicin pharmacokinetics were noted between the therapeutic hypothermia group and the comparator group in elimination rate constant (0.08/h versus 0.11/h; P <0.01), elimination half-life (9.16 hours versus 6.56 hours; P <0.01), and clearance (0.04 L/kg.h versus 0.05 L/kg.h; P <0.01), respectively. Higher gentamicin trough serum concentrations were seen with the therapeutic hypothermia group (1.68 mcg/mL versus 0.77 mcg/mL; P <0.01). CONCLUSIONS:: Therapeutic hypothermia is associated with alterations in gentamicin pharmacokinetics, reducing gentamicin clearance by 25.5% in neonates with hypoxic ischemic encephalopathy, which may result in increased trough serum concentrations.

AB - OBJECTIVE:: To identify whether therapeutic hypothermia in newborns with hypoxic ischemic encephalopathy affects gentamicin pharmacokinetics. STUDY DESIGN:: Retrospective case-control study consisting of 16 neonates who underwent therapeutic hypothermia and received gentamicin with interpretable peak and trough serum levels obtained during the period of cooling and at steady state; comparator group consisting of 7 neonates met the criteria but did not undergo therapeutic hypothermia. RESULTS:: Significant differences in gentamicin pharmacokinetics were noted between the therapeutic hypothermia group and the comparator group in elimination rate constant (0.08/h versus 0.11/h; P <0.01), elimination half-life (9.16 hours versus 6.56 hours; P <0.01), and clearance (0.04 L/kg.h versus 0.05 L/kg.h; P <0.01), respectively. Higher gentamicin trough serum concentrations were seen with the therapeutic hypothermia group (1.68 mcg/mL versus 0.77 mcg/mL; P <0.01). CONCLUSIONS:: Therapeutic hypothermia is associated with alterations in gentamicin pharmacokinetics, reducing gentamicin clearance by 25.5% in neonates with hypoxic ischemic encephalopathy, which may result in increased trough serum concentrations.

KW - aminoglycoside

KW - cooling

KW - hypoxic ischemic encephalopathy

UR - http://www.scopus.com/inward/record.url?scp=84875158199&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875158199&partnerID=8YFLogxK

U2 - 10.1097/FTD.0b013e3182834335

DO - 10.1097/FTD.0b013e3182834335

M3 - Article

VL - 35

SP - 217

EP - 222

JO - Therapeutic Drug Monitoring

JF - Therapeutic Drug Monitoring

SN - 0163-4356

IS - 2

ER -